International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 3 , Pages 701-706 , 1 March 2008

High-Dose-Rate Endobronchial Brachytherapy for Recurrent Airway Obstruction From Hyperplastic Granulation Tissue

  • Rahul D. Tendulkar, M.D.

      Affiliations

    • Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH
    • Corresponding Author InformationReprint requests to: Rahul Tendulkar, M.D., Department of Radiation Oncology, Cleveland Clinic, Desk T-28, 9500 Euclid Avenue, Cleveland, OH 44195. Tel: (216) 445-8292; Fax: (216) 445-1068
    • ,
  • Peter A. Fleming, M.D.

      Affiliations

    • Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH
    • ,
  • Chandana A. Reddy, M.S.

      Affiliations

    • Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH
    • ,
  • Thomas R. Gildea, M.D.

      Affiliations

    • Department of Pulmonary Medicine, Cleveland Clinic, Cleveland, OH
    • ,
  • Michael Machuzak, M.D.

      Affiliations

    • Department of Pulmonary Medicine, Cleveland Clinic, Cleveland, OH
    • ,
  • Atul C. Mehta, M.D.

      Affiliations

    • Department of Pulmonary Medicine, Cleveland Clinic, Cleveland, OH

Received 15 May 2007 ,Revised 3 July 2007 ,Accepted 4 July 2007.

References 

  1. Herrera JM, McNeil KD, Higgins RS, et al. Airway complications after lung transplantation: Treatment and long-term outcomes. Ann Thorac Surg. 2001;71:989–994
  2. Kshettry VR, Kroshus TJ, Hertz MI, et al. Early and late complications after lung transplantation: Incidence and management. Ann Thorac Surg. 1997;63:1576–1583
  3. Saad CP, Murthy S, Krizmanich K, et al. Self-expandable metallic airway stents and flexible bronchoscopy: Long-term outcomes analysis. Chest. 2003;124:1993–1999
  4. Sonett JR, Keenan RJ, Ferson PF, et al. Endobronchial management of benign, malignant, and lung transplantation airway stenoses. Ann Thorac Surg. 1995;59:1417–1422
  5. Chhajed PN, Malouf MA, Tamm M, et al. Interventional bronchoscopy for the management of airway complications following lung transplantation. Chest. 2001;120:1894–1899
  6. Kennedy AS, Sonett JR, Orens JB, et al. High dose rate brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi: Theoretical and clinical considerations. J Heart Lung Transplant. 2000;19:155–159
  7. Kramer MR, Katz A, Yarmolovsky A, et al. Successful use of high dose rate brachytherapy for non-malignant bronchial obstruction. Thorax. 2001;56:415–416
  8. Brenner B, Kramer MR, Katz A, et al. High dose rate brachytherapy for nonmalignant airway obstruction: New treatment option. Chest. 2003;124:1605–1610
  9. Halkos ME, Godette KD, Lawrence EC, et al. High dose rate brachytherapy in the management of lung transplant airway stenosis. Ann Thorac Surg. 2003;76:381–384
  10. Madu CN, Machuzak MS, Sterman DH, et al. High-dose rate (HDR) brachytherapy for the treatment of benign obstructive endobronchial granulation tissue. Int J Radiat Oncol Biol Phys. 2006;66:1450–1456
  11. Rubin P, Williams JP, Riggs PN, et al. Cellular and molecular mechanisms of radiation inhibition of restenosis. Part I: Role of the macrophage and platelet-derived growth factor. Int J Radiat Oncol Biol Phys. 1998;40:929–941
  12. Rubin P, Soni A, Williams JP. The molecular and cellular biologic basis for the radiation treatment of benign proliferative diseases. Semin Radiat Oncol. 1999;9:203–214
  13. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 1997;336:1697–1703
  14. Pokrajaca B, Potter R, Wolfram RM, et al. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. Radiother Oncol. 2005;74:3–9
  15. Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys. 2006;65:1289–1299
  16. Bedwinek J, Petty A, Bruton C, et al. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Int J Radiat Oncol Biol Phys. 1992;22:23–30
  17. Hara R, Itami J, Aruga T, et al. Risk factors for massive hemoptysis after endobronchial brachytherapy in patients with tracheobronchial malignancies. Cancer. 2001;92:2623–2627
  18. Hennequin C, Tredaniel J, Chevret S, et al. Predictive factors for late toxicity after endobronchial brachytherapy: A multivariate analysis. Int J Radiat Oncol Biol Phys. 1998;42:21–27
  19. Nag S, Kelly JF, Horton JL, et al. Brachytherapy for carcinoma of the lung. Oncology. 2001;15:371–381
  20. Kelly JF, Delclos ME, Morice RC, et al. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: The 10-year M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys. 2000;48:697–702
  21. Speiser BL, Spratling L. Remote afterloading brachytherapy for the local control of endobronchial carcinoma. Int J Radiat Oncol Biol Phys. 1993;25:579–587

 Poster presentation at the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), November 5–9, 2006, Philadelphia, PA.

 Conflict of interest: none.

PII: S0360-3016(07)03667-X

doi: 10.1016/j.ijrobp.2007.07.2324

International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 3 , Pages 701-706 , 1 March 2008

Article Tools

* Image Usage & Resolution